ArticleACS omega2025
Efficient Water-Soluble Cu(II) Complex-Immobilized Electrospun Hydrophobic Polycaprolactone Nanofiber Composites for Highly Controlled and Long-Term Release.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Water-soluble Cu complexes offer diverse applications in the biomedical field as Cu is an essential trace element for many physiological functions, including the wound healing process. Controlled delivery of such bioactive Cu complexes to the target system is a promising approach in biomedical applications. Herein, water-soluble Cu(II)-Schiff base complex-incorporated PCL nanofiber composites (PCL@C-1%, PCL@C-3%, and PCL@C-5%) were fabricated by the electrospinning process using a green solvent, acetic acid. Physicochemical properties of the resultant composite nanofibers were investigated by FE-SEM, EDS, TEM, UV-vis, FT-IR, XRD, TGA, BET, and XPS analyses. The successful incorporation of the Cu(II) complex into the PCL nanofiber was confirmed. Water contact angle (WCA) values revealed the hydrophobic nature of the PCL-composite nanofibers, which is also quite beneficial in the wound-healing process as it can create a hydrophobic barrier to prevent extra fluid absorption. To our delight, the release behavior of Cu complexes from the composite nanofibers was found to be gradual, highly controlled, and long-term release (up to 40 days). In addition, the resultant PCL composites demonstrated excellent antibacterial activity against both Gram-positive and Gram-negative bacteria. Overall, these findings provide significant insights into these Cu complex-incorporated PCL nanofiber membranes as potential antibacterial and long-term wound dressings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.